Oslo, Norway, 7 January, 2019 - Photocure ASA (OSE: PHO) management is this week
conducting investor meetings in San Francisco (US) in connection with the J.P.
Morgan healthcare conference.
Please find the presentation attached: JP Morgan Jan
2019 (https://mb.cision.com/Public/17498/2712264/a1e17da1e1e8beff.pdf)
Company contact:
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.no
About Photocure ASA
Photocure, The Bladder Cancer Company, delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com.